Sweden's BioGaia Grows Share In Latin America As Europe Struggles
Executive Summary
BioGaia is now the market leader in Brazil's probiotics category, and has taken second position in the wider Latin American region, thanks to strong growth in the first half of 2021.
You may also be interested in...
EU Business Round-Up: BioGaia Seeks Bigger Slice Of UK, Acino Gets Middle East Backers, Boots Moves Into Advertising
The latest European consumer health business news: BioGaia to distribute full probiotics portfolio in the UK; UAE's ADQ snaps up Switzerland's Acino; and Boots launches a personalized ad offering in the UK.
BioGaia Sees US Investments Paying Off As Q1 Sales Rise
Sweden's BioGaia is looking to capitalize on growing momentum in the US probiotics market with a number of launches. The firm's recent US growth helped to offset falling sales in its more established European markets during the first quarter.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.